(Q41029826)

English

Studies on the susceptibility of 150 consecutive clinical isolates of Pseudomonas aeruginosa to tobramycin, gentamicin, colistin, carbenicillin, and five other antimicrobials

scientific article published on September 1973

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Studies on the susceptibility of 150 consecutive clinical isolates of Pseudomonas aeruginosa to tobramycin, gentamicin, colistin, carbenicillin, and five other antimicrobials (English)

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

0 references

Pseudomonas aeruginosa

1 reference

based on heuristic

inferred from title

author name string

Lockwood WR

1

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Lawson LA

2

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

language of work or name

0 references

publication date

1 September 1973

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

4

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

3

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

281-284

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Two simple media for the demonstration of pyocyanin and fluorescin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444542

26 September 2017

Antibiotic susceptibility testing by a standardized single disk method

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444542

26 September 2017

Tobramycin (Nebramycin Factor 6): In Vitro Activity Against Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444542

26 September 2017

Susceptibility of Pseudomonas aeruginosa to Gentamicin Sulfate In Vitro: Lack of Correlation Between Disc Diffusion and Broth Dilution Sensitivity Data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444542

26 September 2017

In vitro activity of tobramycin and gentamicin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444542

26 September 2017

Tobramycin: in vitro activity and comparison with kanamycin and gentamicin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444542

26 September 2017

In vitro susceptibility testing with tobramycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444542

26 September 2017

In Vitro Evaluation of Tobramycin, a New Aminoglycoside Antibiotic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444542

26 September 2017

In Vitro Studies of Tobramycin, an Aminoglycoside Antibiotic

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444542

26 September 2017

Cross-Resistance of Pseudomonas to Gentamicin and Tobramycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444542

26 September 2017

Evaluation of the in vitro activity of tobramycin as compared with that of gentamicin sulfate

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444542

26 September 2017

Susceptibility of recent isolates of Pseudomonas aeruginosa to gentamicin, polymyxin, and five penicillins, with observations on the pyocin and immunotypes of the strains

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444542

26 September 2017

Pharmacologic Studies on Tobramycin and Comparison with Gentamicin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444542

14 June 2018

Antibiotics for Pseudomonas aeruginosa sepis: inadequate proof of efficacy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=444542

14 June 2018

Nebramycin, a new broad-spectrum antibiotic complex. 3. Isolation and chemical-physical properties

1 reference

https://pubmed.ncbi.nlm.nih.gov/4202342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary studies with nebramycin factor 6

1 reference

https://pubmed.ncbi.nlm.nih.gov/4202342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical assessment of the antibacterial activity of nebramycin factor 6

1 reference

https://pubmed.ncbi.nlm.nih.gov/4202342

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.4.3.281

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

25 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41029826&oldid=2093342353"